Multiple Sclerosis (MS) patients have suffered for so long, but soon, this will no longer be the case. A new treatment known as high-dose immunosuppressive therapy and autologous hematopoietic cell transplant (HDIT/HCT) has been tested and proved to bring lasting solutions to this condition. The study conducted by NIH found out that a patient’s stem cells transplants have immense healing capabilities compared to MS drugs.
According to NIH research on the new treatment procedure, at least sixty-nine percent of patient who received a one-time HDIT/HCT were able to record decrease in MS progression effects, brain lesions, and relapses. The study did not stop there, NIH investigated patients in 24 clinics between the age of 26 and 52 whose MS condition was worsening despite taking MS drugs. According to the findings, HDIT/HCT was able to prevent at least seventy percent of MS cases from getting out of hand. Although HDIT/HCT still calls for further research for its intervention to be more concrete, arguably it is the most preferred treatment compared to MS drugs. One individual who is helping patients and instilling hope in this procedure is Dr. Shiva Gopal Vasishta.
About Dr. Shiva Gopal Vasishta
Dr. Shiva Gopal Vasishta is a Neurologist by profession and is working currently with other 34 neurologists at the Kennedy University Hospital to ensure that patients receive the best care possible. Shiva Gopal is a graduate of the Government Medical College in Nagpur having completed his studies in 1979. Mr. Gopal undertook his vocational training at Boston City Hospital -Major Brain Injury Center that was originally affiliated with Harvard University.
In addition to education qualification, Dr. Shiva Gopal Vasishta is board certified. He undertakes his practice in New Jersey and receives a number of private insurance policies too. His understanding of English and Spanish dialect enables him to extend his services to a huge number of patients.